BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35246508)

  • 21. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NRP-1/shRNA silencing suppresses nasopharyngeal carcinoma cell growth in vitro and in vivo].
    Sun J; Wang L; Lou W; Cao H; Tian X; Sang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 50(4):312-7. PubMed ID: 26081086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
    Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
    Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
    Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
    Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and identification of small hairpin RNA plasmids targeting neuropilin-1 gene and their inhibitory effect on human nasopharyngeal carcinoma CNE-2Z cell proliferation in vitro and in vivo.
    Sun J; Wang L; Lou WH; Cao H; Tian XF; Sang JZ
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2541-7. PubMed ID: 26755049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
    Liu X; Lv XB; Wang XP; Sang Y; Xu S; Hu K; Wu M; Liang Y; Liu P; Tang J; Lu WH; Feng QS; Chen LZ; Qian CN; Bei JX; Kang T; Zeng YX
    Cell Cycle; 2012 Jul; 11(13):2495-506. PubMed ID: 22739938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
    Yang W; Lan X; Li D; Li T; Lu S
    BMC Cancer; 2015 Jun; 15():461. PubMed ID: 26055874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.
    Chiang C; Zhang M; Wang D; Xiao T; Zhu L; Chen K; Huang J; Huang J; Zhu J; Li L; Chen C; Chen Y; Hu H; Jiang W; Zou Y; Wang T; Zheng D
    Theranostics; 2020; 10(17):7906-7920. PubMed ID: 32685028
    [No Abstract]   [Full Text] [Related]  

  • 37. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
    Wang J; Kong J; Nie Z; Chen D; Qiang J; Gao W; Chen X
    Int J Med Sci; 2020; 17(11):1499-1507. PubMed ID: 32669952
    [No Abstract]   [Full Text] [Related]  

  • 38. p38γ is essential for cell cycle progression and liver tumorigenesis.
    Tomás-Loba A; Manieri E; González-Terán B; Mora A; Leiva-Vega L; Santamans AM; Romero-Becerra R; Rodríguez E; Pintor-Chocano A; Feixas F; López JA; Caballero B; Trakala M; Blanco Ó; Torres JL; Hernández-Cosido L; Montalvo-Romeral V; Matesanz N; Roche-Molina M; Bernal JA; Mischo H; León M; Caballero A; Miranda-Saavedra D; Ruiz-Cabello J; Nevzorova YA; Cubero FJ; Bravo J; Vázquez J; Malumbres M; Marcos M; Osuna S; Sabio G
    Nature; 2019 Apr; 568(7753):557-560. PubMed ID: 30971822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma.
    Wong CH; Ma BBY; Hui CWC; Lo KW; Hui EP; Chan ATC
    Sci Rep; 2018 May; 8(1):8010. PubMed ID: 29789630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
    Zhu H
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110249. PubMed ID: 32736275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.